Global Androgenic Alopecia Therapeutics Market Research Report 2024

Androgenic Alopecia Therapeutics Market

Androgenic Alopecia refers to the phenomenon of hair loss, including natural hair loss and pathological hair loss caused by various reasons.

The global Androgenic Alopecia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Androgenic Alopecia Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Androgenic Alopecia Therapeutics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Androgenic Alopecia Therapeutics include Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories and Concert Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Androgenic Alopecia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgenic Alopecia Therapeutics.

Report Scope

The Androgenic Alopecia Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgenic Alopecia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Androgenic Alopecia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Johnson & Johnson

Merck

GlaxoSmithKline

Astellas Pharma

Cipla

Almirall

Sun Pharma

Reddy's Laboratories

Concert Pharmaceuticals

RiverTown Therapeutics

Brickell Biotech

BiologicsMD

Aclaris Therapeutics

Medicine

Surgery

Other

Hospital

Clinic

Other

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Androgenic Alopecia Therapeutics Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androgenic Alopecia Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Medicine

1.2.3 Surgery

1.2.4 Other

1.3 Market by Application

1.3.1 Global Androgenic Alopecia Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Androgenic Alopecia Therapeutics Market Perspective (2019-2030)

2.2 Androgenic Alopecia Therapeutics Growth Trends by Region

2.2.1 Global Androgenic Alopecia Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Androgenic Alopecia Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Androgenic Alopecia Therapeutics Market Dynamics

2.3.1 Androgenic Alopecia Therapeutics Industry Trends

2.3.2 Androgenic Alopecia Therapeutics Market Drivers

2.3.3 Androgenic Alopecia Therapeutics Market Challenges

2.3.4 Androgenic Alopecia Therapeutics Market Restraints

3.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue

3.1.1 Global Top Androgenic Alopecia Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Androgenic Alopecia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Androgenic Alopecia Therapeutics Revenue

3.4 Global Androgenic Alopecia Therapeutics Market Concentration Ratio

3.4.1 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgenic Alopecia Therapeutics Revenue in 2023

3.5 Androgenic Alopecia Therapeutics Key Players Head office and Area Served

3.6 Key Players Androgenic Alopecia Therapeutics Product Solution and Service

3.7 Date of Enter into Androgenic Alopecia Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030)

5.1 Global Androgenic Alopecia Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030)

6.1 North America Androgenic Alopecia Therapeutics Market Size (2019-2030)

6.2 North America Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)

6.4 North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Androgenic Alopecia Therapeutics Market Size (2019-2030)

7.2 Europe Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)

7.4 Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Androgenic Alopecia Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Androgenic Alopecia Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Androgenic Alopecia Therapeutics Market Size (2019-2030)

9.2 Latin America Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Androgenic Alopecia Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Androgenic Alopecia Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Detail

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Androgenic Alopecia Therapeutics Introduction

11.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.1.5 Johnson & Johnson Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Androgenic Alopecia Therapeutics Introduction

11.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.2.5 Merck Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Detail

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Introduction

11.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Development

11.4 Astellas Pharma

11.4.1 Astellas Pharma Company Detail

11.4.2 Astellas Pharma Business Overview

11.4.3 Astellas Pharma Androgenic Alopecia Therapeutics Introduction

11.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.4.5 Astellas Pharma Recent Development

11.5 Cipla

11.5.1 Cipla Company Detail

11.5.2 Cipla Business Overview

11.5.3 Cipla Androgenic Alopecia Therapeutics Introduction

11.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.5.5 Cipla Recent Development

11.6 Almirall

11.6.1 Almirall Company Detail

11.6.2 Almirall Business Overview

11.6.3 Almirall Androgenic Alopecia Therapeutics Introduction

11.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.6.5 Almirall Recent Development

11.7 Sun Pharma

11.7.1 Sun Pharma Company Detail

11.7.2 Sun Pharma Business Overview

11.7.3 Sun Pharma Androgenic Alopecia Therapeutics Introduction

11.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.7.5 Sun Pharma Recent Development

11.8 Reddy's Laboratories

11.8.1 Reddy's Laboratories Company Detail

11.8.2 Reddy's Laboratories Business Overview

11.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Introduction

11.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.8.5 Reddy's Laboratories Recent Development

11.9 Concert Pharmaceuticals

11.9.1 Concert Pharmaceuticals Company Detail

11.9.2 Concert Pharmaceuticals Business Overview

11.9.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Introduction

11.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.9.5 Concert Pharmaceuticals Recent Development

11.10 RiverTown Therapeutics

11.10.1 RiverTown Therapeutics Company Detail

11.10.2 RiverTown Therapeutics Business Overview

11.10.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Introduction

11.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.10.5 RiverTown Therapeutics Recent Development

11.11 Brickell Biotech

11.11.1 Brickell Biotech Company Detail

11.11.2 Brickell Biotech Business Overview

11.11.3 Brickell Biotech Androgenic Alopecia Therapeutics Introduction

11.11.4 Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.11.5 Brickell Biotech Recent Development

11.12 BiologicsMD

11.12.1 BiologicsMD Company Detail

11.12.2 BiologicsMD Business Overview

11.12.3 BiologicsMD Androgenic Alopecia Therapeutics Introduction

11.12.4 BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.12.5 BiologicsMD Recent Development

11.13 Aclaris Therapeutics

11.13.1 Aclaris Therapeutics Company Detail

11.13.2 Aclaris Therapeutics Business Overview

11.13.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Introduction

11.13.4 Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024)

11.13.5 Aclaris Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Medicine

    Table 3. Key Players of Surgery

    Table 4. Key Players of Other

    Table 5. Global Androgenic Alopecia Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Androgenic Alopecia Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Androgenic Alopecia Therapeutics Market Share by Region (2019-2024)

    Table 9. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Androgenic Alopecia Therapeutics Market Share by Region (2025-2030)

    Table 11. Androgenic Alopecia Therapeutics Market Trends

    Table 12. Androgenic Alopecia Therapeutics Market Drivers

    Table 13. Androgenic Alopecia Therapeutics Market Challenges

    Table 14. Androgenic Alopecia Therapeutics Market Restraints

    Table 15. Global Androgenic Alopecia Therapeutics Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Androgenic Alopecia Therapeutics Market Share by Players (2019-2024)

    Table 17. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)

    Table 18. Ranking of Global Top Androgenic Alopecia Therapeutics Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Androgenic Alopecia Therapeutics Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Androgenic Alopecia Therapeutics Product Solution and Service

    Table 22. Date of Enter into Androgenic Alopecia Therapeutics Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Androgenic Alopecia Therapeutics Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2019-2024)

    Table 26. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Androgenic Alopecia Therapeutics Revenue Market Share by Type (2025-2030)

    Table 28. Global Androgenic Alopecia Therapeutics Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2019-2024)

    Table 30. Global Androgenic Alopecia Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Androgenic Alopecia Therapeutics Revenue Market Share by Application (2025-2030)

    Table 32. North America Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Androgenic Alopecia Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Androgenic Alopecia Therapeutics Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Androgenic Alopecia Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2025-2030) & (US$ Million)

    Table 47. Johnson & Johnson Company Detail

    Table 48. Johnson & Johnson Business Overview

    Table 49. Johnson & Johnson Androgenic Alopecia Therapeutics Product

    Table 50. Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 51. Johnson & Johnson Recent Development

    Table 52. Merck Company Detail

    Table 53. Merck Business Overview

    Table 54. Merck Androgenic Alopecia Therapeutics Product

    Table 55. Merck Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 56. Merck Recent Development

    Table 57. GlaxoSmithKline Company Detail

    Table 58. GlaxoSmithKline Business Overview

    Table 59. GlaxoSmithKline Androgenic Alopecia Therapeutics Product

    Table 60. GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 61. GlaxoSmithKline Recent Development

    Table 62. Astellas Pharma Company Detail

    Table 63. Astellas Pharma Business Overview

    Table 64. Astellas Pharma Androgenic Alopecia Therapeutics Product

    Table 65. Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 66. Astellas Pharma Recent Development

    Table 67. Cipla Company Detail

    Table 68. Cipla Business Overview

    Table 69. Cipla Androgenic Alopecia Therapeutics Product

    Table 70. Cipla Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 71. Cipla Recent Development

    Table 72. Almirall Company Detail

    Table 73. Almirall Business Overview

    Table 74. Almirall Androgenic Alopecia Therapeutics Product

    Table 75. Almirall Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 76. Almirall Recent Development

    Table 77. Sun Pharma Company Detail

    Table 78. Sun Pharma Business Overview

    Table 79. Sun Pharma Androgenic Alopecia Therapeutics Product

    Table 80. Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 81. Sun Pharma Recent Development

    Table 82. Reddy's Laboratories Company Detail

    Table 83. Reddy's Laboratories Business Overview

    Table 84. Reddy's Laboratories Androgenic Alopecia Therapeutics Product

    Table 85. Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 86. Reddy's Laboratories Recent Development

    Table 87. Concert Pharmaceuticals Company Detail

    Table 88. Concert Pharmaceuticals Business Overview

    Table 89. Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product

    Table 90. Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 91. Concert Pharmaceuticals Recent Development

    Table 92. RiverTown Therapeutics Company Detail

    Table 93. RiverTown Therapeutics Business Overview

    Table 94. RiverTown Therapeutics Androgenic Alopecia Therapeutics Product

    Table 95. RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 96. RiverTown Therapeutics Recent Development

    Table 97. Brickell Biotech Company Detail

    Table 98. Brickell Biotech Business Overview

    Table 99. Brickell Biotech Androgenic Alopecia Therapeutics Product

    Table 100. Brickell Biotech Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 101. Brickell Biotech Recent Development

    Table 102. BiologicsMD Company Detail

    Table 103. BiologicsMD Business Overview

    Table 104. BiologicsMD Androgenic Alopecia Therapeutics Product

    Table 105. BiologicsMD Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 106. BiologicsMD Recent Development

    Table 107. Aclaris Therapeutics Company Detail

    Table 108. Aclaris Therapeutics Business Overview

    Table 109. Aclaris Therapeutics Androgenic Alopecia Therapeutics Product

    Table 110. Aclaris Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2019-2024) & (US$ Million)

    Table 111. Aclaris Therapeutics Recent Development

    Table 112. Research Programs/Design for This Report

    Table 113. Key Data Information from Secondary Sources

    Table 114. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Androgenic Alopecia Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Androgenic Alopecia Therapeutics Market Share by Type: 2023 VS 2030

    Figure 3. Medicine Features

    Figure 4. Surgery Features

    Figure 5. Other Features

    Figure 6. Global Androgenic Alopecia Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Androgenic Alopecia Therapeutics Market Share by Application: 2023 VS 2030

    Figure 8. Hospital Case Studies

    Figure 9. Clinic Case Studies

    Figure 10. Other Case Studies

    Figure 11. Androgenic Alopecia Therapeutics Report Years Considered

    Figure 12. Global Androgenic Alopecia Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Androgenic Alopecia Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Androgenic Alopecia Therapeutics Market Share by Region: 2023 VS 2030

    Figure 15. Global Androgenic Alopecia Therapeutics Market Share by Players in 2023

    Figure 16. Global Top Androgenic Alopecia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgenic Alopecia Therapeutics as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Androgenic Alopecia Therapeutics Revenue in 2023

    Figure 18. North America Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)

    Figure 20. United States Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)

    Figure 24. Germany Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Androgenic Alopecia Therapeutics Market Share by Region (2019-2030)

    Figure 32. China Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)

    Figure 40. Mexico Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Country (2019-2030)

    Figure 44. Turkey Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Androgenic Alopecia Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Johnson & Johnson Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 47. Merck Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 48. GlaxoSmithKline Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 49. Astellas Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 50. Cipla Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 51. Almirall Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 52. Sun Pharma Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 53. Reddy's Laboratories Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 54. Concert Pharmaceuticals Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 55. RiverTown Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 56. Brickell Biotech Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 57. BiologicsMD Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 58. Aclaris Therapeutics Revenue Growth Rate in Androgenic Alopecia Therapeutics Business (2019-2024)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed